Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
Condition(s):Drug InteractionsLast Updated:September 7, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Drug InteractionsLast Updated:September 7, 2016Completed
Condition(s):Neuroendocrine TumorsLast Updated:September 9, 2020Completed
Condition(s):AcromegalyLast Updated:September 20, 2013Terminated
Condition(s):Haemorrhagic Shock; Variceal HemorrhageLast Updated:February 9, 2023Withdrawn
Condition(s):AcromegalyLast Updated:November 3, 2022Suspended
Condition(s):Gastro-entero-pancreatic Carcinoma; Esophageal Neuroendocrine CarcinomaLast Updated:April 7, 2015Unknown status
Condition(s):AcromegalyLast Updated:August 10, 2012Unknown status
Condition(s):Prader-Willi SyndromeLast Updated:July 24, 2014Terminated
Condition(s):Neuroendocrine TumorsLast Updated:February 13, 2023Recruiting
Condition(s):AcromegalyLast Updated:August 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.